HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Dihydroquinoline Carbamate DQS1-02 as a Prodrug of a Potent Acetylcholinesterase Inhibitor for Alzheimer’s Disease Therapy: Multigram-Scale Synthesis, Mechanism Investigations, in Vitro Safety Pharmacology, and Preliminary in Vivo Toxicology Profile

Abstract : We previously characterized a set of potent pseudo-irreversible inhibitors of acetylcholinesterase (AChE) based on a redox prodrug strategy. Among the various synthesized prodrugs, compound 1, namely DQS1-02, displayed favorable physicochemical properties and was chosen to achieve the necessary prerequisite investigations prior to preclinical evaluation. Herein, we first report a practical multigram-scale nine-step synthesis of prodrug 1 with a good overall yield (18%) as well as a full investigation on the inhibition mechanism of AChE by the parent drug 2 by means of UV−vis spectroscopy, NMR, and tandem mass spectrometry. In the second part, we describe the ADME properties of DQS1-02, the safety pharmacology of both compounds 1 and 2, and the preliminary results of an in vivo toxicology study in rats. Last but not the least, we also demonstrated that AChE inhibitor 2 was highly selective for AChE, whereas the corresponding prodrug 1 proved to be remarkably safe, making it a valuable preclinical candidate.
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03134333
Contributor : Cyril Papamicael Connect in order to contact the contributor
Submitted on : Monday, February 8, 2021 - 11:33:16 AM
Last modification on : Tuesday, May 10, 2022 - 2:48:02 PM
Long-term archiving on: : Sunday, May 9, 2021 - 7:04:38 PM

File

ACS Omega 2018.pdf
Publisher files allowed on an open archive

Identifiers

Citation

Florent Alix, Vincent Gembus, Laurent Coquet, Marie Hubert-Roux, Philippe Chan, et al.. Dihydroquinoline Carbamate DQS1-02 as a Prodrug of a Potent Acetylcholinesterase Inhibitor for Alzheimer’s Disease Therapy: Multigram-Scale Synthesis, Mechanism Investigations, in Vitro Safety Pharmacology, and Preliminary in Vivo Toxicology Profile. ACS Omega, ACS Publications, 2018, 3 (12), pp.18387-18397. ⟨10.1021/acsomega.8b02121⟩. ⟨hal-03134333⟩

Share

Metrics

Record views

59

Files downloads

27